- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 35/545 - Embryonic stem cellsPluripotent stem cellsInduced pluripotent stem cellsUncharacterised stem cells
Patent holdings for IPC class A61K 35/545
Total number of patents in this class: 1345
10-year publication summary
|
96
|
86
|
127
|
126
|
101
|
112
|
108
|
127
|
121
|
52
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 19989 |
45 |
| Kyoto University | 2803 |
30 |
| Tohoku University | 2790 |
27 |
| FATE Therapeutics, Inc. | 206 |
26 |
| Osaka University | 3384 |
20 |
| Healios K.K. | 105 |
17 |
| Sumitomo Pharma Co., Ltd. | 604 |
17 |
| Life Science Institute, Inc | 56 |
16 |
| The Board of Trustees of the Leland Stanford Junior University | 6433 |
14 |
| President and Fellows of Harvard College | 5993 |
14 |
| CRISPR Therapeutics AG | 366 |
14 |
| Memorial Sloan-Kettering Cancer Center | 1936 |
14 |
| Riken | 1690 |
14 |
| University of Washington | 2338 |
12 |
| Minovia Therapeutics Ltd. | 52 |
11 |
| Children's Medical Center Corporation | 1877 |
10 |
| Sumitomo Dainippon Pharma Co., Ltd. | 216 |
10 |
| ViaCyte, Inc. | 179 |
10 |
| The Johns Hopkins University | 5679 |
9 |
| Sumitomo Chemical Company, Limited | 9047 |
8 |
| Other owners | 1007 |